| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035059 For achieving circadian rhythm phase-shifting effect in mammal |
| 03/21/2002 | US20020034796 Electroactive materials for stimulation of biological activity of stem cells |
| 03/21/2002 | US20020034725 Sensitization of cells to radiation and and chemotherapy |
| 03/21/2002 | US20020034537 For enhancing selective delivery of therapeutic, diagnostic and imaging agents to activated vascular sites |
| 03/21/2002 | US20020033989 Methods and apparatus for optical imaging |
| 03/21/2002 | CA2421792A1 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1187609A1 Treatment and analysis of proliferative disorders |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/14/2002 | WO2002020015A1 Inhibitors of prenyl-protein transferase |
| 03/13/2002 | EP1185309A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 03/13/2002 | CN1339969A Liposone composition and method for administration of a radiosensitizer |
| 03/12/2002 | US6355238 Specific immune system modulation |
| 03/12/2002 | US6354297 Method and device for destroying fat cells by induction of programmed cell death |
| 03/07/2002 | WO2002017925A1 Non-symmetric tripyrrannes in the synthesis of novel macrocycles |
| 03/07/2002 | WO2002017910A1 Agents for neutron capture therapy |
| 03/07/2002 | WO2002017908A1 Novel metallotexaphyrin derivatives |
| 03/07/2002 | WO2001097750A3 Method for producing an antiviral agent |
| 03/07/2002 | WO2001055092B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 03/07/2002 | WO2001034199A3 Oncolytic combinations for the treatment of cancer |
| 03/07/2002 | WO2001032211A3 Conjugate compounds for treating atheroma and other diseases |
| 03/07/2002 | US20020026945 Enhancement of photodynamic therapy by anti-angiogenic treatment |
| 03/07/2002 | CA2434744A1 Novel metallotexaphyrin derivatives |
| 03/06/2002 | EP1183071A1 Cosmetic depilation kit with photosensitizer |
| 03/05/2002 | US6352683 Apparatus and method for the local delivery of drugs |
| 03/05/2002 | US6352506 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 02/28/2002 | WO2001082860A3 Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy |
| 02/28/2002 | WO2001037875A3 Method for bestowing a medicinal or biological relieving effect on an electrically-powered device |
| 02/28/2002 | US20020025311 Applying localized energy to the area to be treated and administering a biologically acceptable chemical substance capable of breaking the chemical bonds between disulfates of the cortical lens fibers |
| 02/28/2002 | US20020025298 Use of texaphyrin in ocular diagnosis and therapy |
| 02/27/2002 | EP1181394A2 Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof |
| 02/27/2002 | EP1181026A2 Improved method for treating mammals with modified mammalian blood |
| 02/27/2002 | EP1027034B1 Marker for intestinal diagnosis and intestinal therapy |
| 02/27/2002 | EP1023399A4 Novel methods of syntheses of phthalocyanine compounds |
| 02/27/2002 | CN1337886A Method for improved radiation therapy |
| 02/26/2002 | US6351663 Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation |
| 02/26/2002 | US6350772 Treatment of auto-immune diseases by photochemotherapy |
| 02/26/2002 | US6350431 Light image contrast agent with chromopores linked with polyether |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002013863A2 Presbyopia treatment by lens alteration |
| 02/21/2002 | WO2002013820A1 Photosensitizing ointment |
| 02/21/2002 | WO2002013788A1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| 02/21/2002 | US20020022215 Inactivation of small non-enveloped viruses and other microbial pathogens by porphyrins |
| 02/21/2002 | US20020022032 Immuno-adjuvant PDT treatment of metastatic tumors |
| 02/21/2002 | US20020022027 Complexing to polypeptides; antiproliferation agent |
| 02/21/2002 | DE19957077A1 Verfahren zum Aufbringen einer medizinischen oder biologisch entlastenden Wirkung auf eine strombetriebene Einrichtung A method of applying a medical or biologically-relieving effect on a powered device |
| 02/20/2002 | EP0909182B1 Method for producing chlorins and bacteriochlorins containing polyether |
| 02/20/2002 | CN1336174A Anticancer compoiste light ball with X-ray stimulated zinc oxide-porphyrin compound |
| 02/19/2002 | US6348453 Methods for treating viral infections |
| 02/14/2002 | WO2002012131A2 Antioxidants in clusters of structured water |
| 02/14/2002 | WO2002011764A2 Pharmaceutical compositions |
| 02/14/2002 | WO2002011730A1 Radiosensitising agent for curing oncological diseases |
| 02/14/2002 | WO2002011713A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 02/14/2002 | WO2002011539A1 Methods and compositions for treating skin ulcers by topical photodynamic therapy |
| 02/14/2002 | WO2001055092A3 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 02/14/2002 | WO2001034198A3 Oncolytic combinations for the treatment of cancer |
| 02/14/2002 | US20020019385 Activator protein (AP); treating diseases associated with immune suppressive states; benzmides such as N-((2-Diethylamino)propyl)-4-isobutyrylamino-2-methoxy-benzamide |
| 02/14/2002 | US20020019366 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 02/14/2002 | US20020019356 Hyperbaric oxigenation (hbo) as the method for enhancement efficiency of anti-hiv substances in inhibition the human immunodeficiency virus (hiv) reproduction and reduction of the cytotoxic effect of those substances as well |
| 02/14/2002 | US20020018752 Ablation disease by cutting, blocking blood supply to tissue |
| 02/13/2002 | EP1178830A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 02/12/2002 | US6346529 Antiviral therapy using thiazine dyes |
| 02/07/2002 | WO2002010173A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002010119A1 Preparation of sterile crystals of 5-aminolevulinic acid utilized for medical diagnostic and therapeutic purposes, and a device for facilitating this diagnostic process |
| 02/07/2002 | WO2001032210A3 Compositions for treating atheroma and neoplastic tissue |
| 02/07/2002 | CA2416523A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | CA2416307A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 02/05/2002 | US6344272 Metal nanoshells |
| 02/05/2002 | US6344050 For use in administering photodynamic therapy; conjugate of a microparticle, a photosensitizer, an antibody and a polymer |
| 01/31/2002 | WO2002007819A1 Enhancement of photodynamic therapy by anti-angiogenic treatment |
| 01/31/2002 | WO2001056546A3 Magnetoliposome composition for targeted treatment of biological tissue |
| 01/31/2002 | US20020012663 Inhibiting the growth of refractory tumors that are stimulated by a ligand of epidermal growth factor receptor (EGFR) in human patients, comprising treating the human patients with an effective amount of an EGFR/HER1 antagonist |
| 01/30/2002 | EP1175212A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 01/30/2002 | EP1001765A4 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells |
| 01/29/2002 | US6342217 Radiation enhanced gene therapy for tumors expressing a gene for a viral pyrimidine kinase in the presence of a 5′-halogenated pyrimidine |
| 01/29/2002 | CA2207624C Selective and non-invasive visualization or treatment of vasculature |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2001032154A3 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 01/24/2002 | DE10031851A1 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
| 01/23/2002 | EP1173203A2 Immuno-adjuvant pdt treatment of metastatic tumors |
| 01/23/2002 | CN1332648A Method of providing cosmetic/medical therapy |
| 01/17/2002 | WO2002004067A1 Method and device for avoiding alteration of a substance having biological activities |
| 01/17/2002 | WO2002004023A2 Photoactivated drug therapy |
| 01/17/2002 | WO2002003850A2 Photoselective marking of biological targets |
| 01/17/2002 | WO2002003800A1 Device and method for photoactivated drug therapy |
| 01/17/2002 | WO1999051284A3 Non-covalent bioconjugates useful for diagnosis and therapy |
| 01/17/2002 | US20020006404 Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | US20020006393 Compounds for the photodecontamination of pathogens in blood |
| 01/17/2002 | US20020006378 Paramagnetism, photosensitivity; imaging, diagnosis, drug delivery |
| 01/16/2002 | EP1171162A2 Cobalamin conjugates useful as antitumor agents |
| 01/16/2002 | EP1171144A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 01/16/2002 | EP1171140A2 Treatment of hypersensitivity reaction disorders |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | CN1331797A High energy phototherapeutic agents |
| 01/10/2002 | WO2002002153A1 Inactivation of pathogens by porphyrins |